KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $503.3 million.

  • Medpace Holdings' Other Operating Expenses rose 4035.21% to $503.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.8 billion, marking a year-over-year increase of 2175.42%. This contributed to the annual value of $1.8 billion for FY2025, which is 2175.42% up from last year.
  • As of Q4 2025, Medpace Holdings' Other Operating Expenses stood at $503.3 million, which was up 4035.21% from $463.2 million recorded in Q3 2025.
  • Over the past 5 years, Medpace Holdings' Other Operating Expenses peaked at $503.3 million during Q4 2025, and registered a low of $182.8 million during Q1 2021.
  • In the last 5 years, Medpace Holdings' Other Operating Expenses had a median value of $346.7 million in 2023 and averaged $321.9 million.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first plummeted by 96.98% in 2024, then skyrocketed by 4035.21% in 2025.
  • Medpace Holdings' Other Operating Expenses (Quarter) stood at $221.8 million in 2021, then rose by 25.85% to $279.2 million in 2022, then increased by 29.71% to $362.1 million in 2023, then fell by 0.97% to $358.6 million in 2024, then skyrocketed by 40.35% to $503.3 million in 2025.
  • Its last three reported values are $503.3 million in Q4 2025, $463.2 million for Q3 2025, and $423.5 million during Q2 2025.